$CMPX
Compass Therapeutics, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Boston, MA
CMPX chart
What traders are saying about $CMPX
Latest postsCompass Therapeutics, Inc. news
- symbol__ Stock Quote Price and Forecast
CNN ·
- Compass Therapeutics, Inc. Estimates – NASDAQ:CMPX
TradingView ·
- Compass Therapeutics publishes tovecimig trial results in JCO
Investing.com ·
- Phase 2 3 COMPANION 002 study findings released by Compass Therapeutics
Traders Union ·
- Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026
Yahoo Finance ·
- A Quick Look at Today's Ratings for Compass Therapeutics(CMPX.US), With a Forecast Between $4 to $12
Moomoo ·
- Emergent BioSolutions stock falls as CFO plans retirement
Yahoo Finance ·
- Compass Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Compass Therapeutics (CMPX) Stock Fair Value Falls After Tovecimig Regulatory Concerns
Yahoo Finance ·
- Compass Therapeutics’ FDA Setback Raises Concerns On Wall Street — H.C. Wainwright Calls Tovecimig Filing Strategy ‘Risky’
stocktwits.com ·
- CMPX Plunge Wipes Out $104M After FDA Demands Fresh Trial For Cancer Drug — Wedbush Sees Another 19% Downside
stocktwits.com ·
- Sector Update: Healthcare Stocks Rise Late Afternoon
Yahoo Finance ·
Compass Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$66.5M | -$49.4M | -$42.5M | -$39.2M |
| Total assets (year end) | $219.6M | $140.4M | $156.9M | $199.6M |
| Cash and equivalents (year end) | $30.6M | $43.5M | $24.2M | $34.9M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Compass Therapeutics, Inc.
- Ticker
- CMPX (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Boston, MA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1738021
- Former names
- Olivia Ventures, Inc.
Frequently asked questions
What exchange is Compass Therapeutics, Inc. listed on?
Compass Therapeutics, Inc. trades on the Nasdaq under the ticker symbol CMPX.
What industry is Compass Therapeutics, Inc. in?
Compass Therapeutics, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Compass Therapeutics, Inc. headquartered?
Compass Therapeutics, Inc.'s business address on file with the SEC is in Boston, MA.
When does Compass Therapeutics, Inc.'s fiscal year end?
Compass Therapeutics, Inc.'s fiscal year ends on December 31.